Literature DB >> 25677977

In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance.

Nadine T Gaisa1, Holger Wilms, Peter J Wild, Gerhard Jakse, Axel Heidenreich, Ruth Knuechel.   

Abstract

Histological tumor subtyping, staging, and grading are of utmost importance to stratify patients with bladder cancer for treatment and should be as precise as possible. In the presented study, we investigated the prognostic impact of standard clinicopathological parameters in cystectomy patients and compared embedding of the entire bladder with standard partial embedding via a virtual superimposed approach. The study included 121 cystectomy specimens, which were completely embedded. Clinical and histopathological data of patients were obtained (median follow-up 21.5 months; range 1-67 months). For 88 patients two-dimensional tumor maps (macrophotographs and histology-based maps) were prepared, and embedding of the entire bladder was compared with a virtual standard partial embedding, created by a virtual overlay and data extraction of the tumor maps. Kaplan-Meier plots, Cox regression estimators, Chi-square, and McNemar tests were used. In a multivariate Cox regression model for overall survival, only venous invasion (p = 0.008, HR = 3.35, 95 % CI 1.375-8.161) and organ-confined (pTis-pT2) versus non-organ-confined diseases (pT3-pT4; p = 0.021, HR 2.669, 95 % CI 1.157-6.159) were found significant. Advanced versus standard embedding revealed significant improvement in the detection of carcinoma in situ (50 versus 61, p = 0.003) and lymphatic invasion (18 versus 24, p = 0.041), but no significant advantage in the detection of tumor stage, tumor multifocality, or venous invasion (all p > 0.05). TNM classification, including lymphatic and venous invasion, is of utmost importance to stratify patients with advanced invasive bladder cancer. Histopathological details are detected more reliably by whole organ embedding, but this approach showed no significant benefit in terms of outcome-related parameters (max. tumor stage, venous invasion) in our cohort.

Entities:  

Mesh:

Year:  2015        PMID: 25677977     DOI: 10.1007/s00428-015-1726-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.

Authors:  Yair Lotan; Amit Gupta; Shahrokh F Shariat; Ganesh S Palapattu; Amnon Vazina; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad Amiel; Paul Perotte; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky
Journal:  J Clin Oncol       Date:  2005-08-22       Impact factor: 44.544

2.  Precise morphologic documentation with large-format histology of clinical findings in a bladder cancer patient.

Authors:  Andrea B Galosi; Liang Cheng; Antonio Lopez-Beltran; Francesco Montorsi; Marina Scarpelli; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

3.  Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy.

Authors:  Farkas Sükösd; Béla Iványi; László Pajor
Journal:  Pathol Oncol Res       Date:  2014-02-23       Impact factor: 3.201

4.  Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.

Authors:  Michael Rink; Jens Hansen; Eugene K Cha; David A Green; Marko Babjuk; Robert S Svatek; Evanguelos Xylinas; Scott T Tagawa; Talia Faison; Giacomo Novara; Pierre I Karakiewicz; Siamak Daneshmand; Yair Lotan; Wassim Kassouf; Hans-Martin Fritsche; Armin Pycha; Evi Comploj; Derya Tilki; Patrick J Bastian; Felix K Chun; Roland Dahlem; Douglas S Scherr; Shahrokh F Shariat
Journal:  BJU Int       Date:  2012-07-19       Impact factor: 5.588

5.  Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.

Authors:  Dengfeng Cao; Robin T Vollmer; Jason Luly; Samay Jain; Timur M Roytman; Charles W Ferris; M'liss Ann Hudson
Journal:  Urology       Date:  2010-04-08       Impact factor: 2.649

6.  Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.

Authors:  Chin-Chen Pan; Yen-Hwa Chang; Kuang-Kuo Chen; Hui-Jung Yu; Chih-Hao Sun; Donald M T Ho
Journal:  Am J Clin Pathol       Date:  2010-05       Impact factor: 2.493

7.  Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.

Authors:  Philipp Nuhn; Patrick J Bastian; Giacomo Novara; Robert S Svatek; Pierre I Karakiewicz; Eila Skinner; Yves Fradet; Jonathan I Izawa; Wassim Kassouf; Francesco Montorsi; Stefan C Müller; Hans-Martin Fritsche; Guru Sonpavde; Derya Tilki; Hendrik Isbarn; Vincenzo Ficarra; Colin P Dinney; Shahrokh F Shariat
Journal:  Urol Int       Date:  2011-06-09       Impact factor: 2.089

8.  Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.

Authors:  Hans-Martin Fritsche; Matthias May; Stefan Denzinger; Wolfgang Otto; Sabine Siegert; Christian Giedl; Johannes Giedl; Fabian Eder; Abbas Agaimy; Vladimir Novotny; Manfred Wirth; Christian Stief; Sabine Brookman-May; Ferdinand Hofstädter; Michael Gierth; Atiqullah Aziz; Arkadius Kocot; Hubertus Riedmiller; Patrick J Bastian; Marieta Toma; Wolf F Wieland; Arndt Hartmann; Maximilian Burger
Journal:  Eur Urol       Date:  2012-09-28       Impact factor: 20.096

Review 9.  A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens.

Authors:  Donna E Hansel; Mahul B Amin; Eva Comperat; Richard J Cote; Ruth Knüchel; Rodolfo Montironi; Victor E Reuter; Mark S Soloway; Saleem A Umar; Theodorus H Van der Kwast
Journal:  Eur Urol       Date:  2012-10-12       Impact factor: 20.096

10.  Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.

Authors:  Derya Tilki; Shahrokh F Shariat; Yair Lotan; Michael Rink; Pierre I Karakiewicz; Mark P Schoenberg; Seth P Lerner; Guru Sonpavde; Arthur I Sagalowsky; Amit Gupta
Journal:  BJU Int       Date:  2012-11-26       Impact factor: 5.588

View more
  4 in total

1.  Response letter to "What can be more prognostic than the pTNM category assessed in radical cystectomy samples?" by Sükösd F, Ivanyi B and Pajor L.

Authors:  Nadine T Gaisa; Ruth Knüchel-Clarke
Journal:  Virchows Arch       Date:  2015-08-21       Impact factor: 4.064

2.  What can be more prognostic than the pTNM category assessed on radical cystectomy specimens?

Authors:  Farkas Sükösd; Béla Iványi; László Pajor
Journal:  Virchows Arch       Date:  2015-08-23       Impact factor: 4.064

3.  Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.

Authors:  Lijin Zhang; Bin Wu; Zhenlei Zha; Hu Zhao; Jun Yuan; Yuefang Jiang
Journal:  World J Urol       Date:  2019-03-27       Impact factor: 4.226

Review 4.  [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].

Authors:  N T Gaisa
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.